Antibody-mediated disruption of the interaction between PCSK9 and the low-density lipoprotein receptor

PCSK9 (proprotein convertase subtilisin/kexin type 9) promotes degradation of the LDLR [LDL (low-density lipoprotein) receptor] through an as-yet-undefined mechanism, leading to a reduction in cellular LDLc (LDL-cholesterol) and a concomitant increase in serum LDLc. Central to the function of PCSK9...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Duff, Christopher J., Scott, Martin J., Kirby, Ian T., Hutchinson, Sue E., Martin, Steve L., Hooper, Nigel M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Portland Press Ltd. 2009
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2669217/
https://ncbi.nlm.nih.gov/pubmed/19196236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20082407
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia